Optimizing outcomes: adherence to the ABC (Atrial fibrillation Better Care) pathway in Asian atrial fibrillation patients with chronic kidney disease

Atrial fibrillation (AF) is the most prevalent form of cardiac arrhythmia, representing a significant burden on both healthcare systems and public health.1,2 It is associated with increased risks of mortality and morbidity, as well as with complications such as stroke, heart failure, and frequent hospitalizations.1,2 Despite advances in the use of oral anticoagulants (OACs), many AF patients still suffer from multiple comorbidities, contributing to their high cardiovascular and all-cause mortality rates.